Cargando…
Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis
AIMS: Chronic pressure overload and right ventricular (RV) dysfunction can lead to RV–pulmonary artery (PA) uncoupling in patients with heart failure. The evolution and prognostic values of RV–PA coupling assessed by echocardiography in patients undergoing cardiac resynchronization therapy (CRT) hav...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065855/ https://www.ncbi.nlm.nih.gov/pubmed/35266319 http://dx.doi.org/10.1002/ehf2.13857 |
_version_ | 1784699680482918400 |
---|---|
author | Stassen, Jan Galloo, Xavier Hirasawa, Kensuke Chimed, Surenjav Marsan, Nina Ajmone Delgado, Victoria van der Bijl, Pieter Bax, Jeroen J. |
author_facet | Stassen, Jan Galloo, Xavier Hirasawa, Kensuke Chimed, Surenjav Marsan, Nina Ajmone Delgado, Victoria van der Bijl, Pieter Bax, Jeroen J. |
author_sort | Stassen, Jan |
collection | PubMed |
description | AIMS: Chronic pressure overload and right ventricular (RV) dysfunction can lead to RV–pulmonary artery (PA) uncoupling in patients with heart failure. The evolution and prognostic values of RV–PA coupling assessed by echocardiography in patients undergoing cardiac resynchronization therapy (CRT) have not been thoroughly investigated. The aim of this study was to evaluate the evolution and prognostic value of tricuspid annular plane systolic excursion (TAPSE)/pulmonary artery systolic pressure (PASP) ratio in CRT recipients. METHODS AND RESULTS: The RV–PA coupling was measured non‐invasively with echocardiography using the TAPSE/PASP ratio at baseline and 6 month follow‐up in CRT recipients. The cut‐off value for TAPSE/PASP uncoupling was derived from spline curve analysis (i.e. <0.45 mm/mmHg). The primary endpoint was all‐cause mortality. A total of 807 patients (age 66 ± 11 years, 76% men) were analysed. During a median follow‐up of 97 (54–143) months, 483 (60%) patients died. Survival rates at 3 and 5 year follow‐up were significantly lower for patients with a TAPSE/PASP ratio <0.45 mm/mmHg (76% and 58%, respectively), compared with those with a TAPSE/PASP ratio ≥0.45 mm/mmHg (91% and 82%, respectively) (P < 0.001). On multivariable analysis, TAPSE/PASP ratio <0.45 mm/mmHg (hazard ratio 1.437; 95% confidence interval: 1.145–1.805; P = 0.002) was independently associated with all‐cause mortality, whereas TAPSE <17 mm (hazard ratio 1.237; 95% confidence interval: 0.990–1.546; P = 0.061) was not. In addition, no improvement of the TAPSE/PASP ratio after CRT implantation was independently associated with worse survival. CONCLUSIONS: The TAPSE/PASP ratio at baseline is independently associated with long‐term outcomes in CRT recipients. The baseline TAPSE/PASP ratio has incremental value over TAPSE, which does not take account of RV afterload. A lack of improvement in the TAPSE/PASP ratio after CRT implantation is associated with worse survival. |
format | Online Article Text |
id | pubmed-9065855 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90658552022-05-04 Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis Stassen, Jan Galloo, Xavier Hirasawa, Kensuke Chimed, Surenjav Marsan, Nina Ajmone Delgado, Victoria van der Bijl, Pieter Bax, Jeroen J. ESC Heart Fail Original Articles AIMS: Chronic pressure overload and right ventricular (RV) dysfunction can lead to RV–pulmonary artery (PA) uncoupling in patients with heart failure. The evolution and prognostic values of RV–PA coupling assessed by echocardiography in patients undergoing cardiac resynchronization therapy (CRT) have not been thoroughly investigated. The aim of this study was to evaluate the evolution and prognostic value of tricuspid annular plane systolic excursion (TAPSE)/pulmonary artery systolic pressure (PASP) ratio in CRT recipients. METHODS AND RESULTS: The RV–PA coupling was measured non‐invasively with echocardiography using the TAPSE/PASP ratio at baseline and 6 month follow‐up in CRT recipients. The cut‐off value for TAPSE/PASP uncoupling was derived from spline curve analysis (i.e. <0.45 mm/mmHg). The primary endpoint was all‐cause mortality. A total of 807 patients (age 66 ± 11 years, 76% men) were analysed. During a median follow‐up of 97 (54–143) months, 483 (60%) patients died. Survival rates at 3 and 5 year follow‐up were significantly lower for patients with a TAPSE/PASP ratio <0.45 mm/mmHg (76% and 58%, respectively), compared with those with a TAPSE/PASP ratio ≥0.45 mm/mmHg (91% and 82%, respectively) (P < 0.001). On multivariable analysis, TAPSE/PASP ratio <0.45 mm/mmHg (hazard ratio 1.437; 95% confidence interval: 1.145–1.805; P = 0.002) was independently associated with all‐cause mortality, whereas TAPSE <17 mm (hazard ratio 1.237; 95% confidence interval: 0.990–1.546; P = 0.061) was not. In addition, no improvement of the TAPSE/PASP ratio after CRT implantation was independently associated with worse survival. CONCLUSIONS: The TAPSE/PASP ratio at baseline is independently associated with long‐term outcomes in CRT recipients. The baseline TAPSE/PASP ratio has incremental value over TAPSE, which does not take account of RV afterload. A lack of improvement in the TAPSE/PASP ratio after CRT implantation is associated with worse survival. John Wiley and Sons Inc. 2022-03-09 /pmc/articles/PMC9065855/ /pubmed/35266319 http://dx.doi.org/10.1002/ehf2.13857 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Stassen, Jan Galloo, Xavier Hirasawa, Kensuke Chimed, Surenjav Marsan, Nina Ajmone Delgado, Victoria van der Bijl, Pieter Bax, Jeroen J. Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis |
title | Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis |
title_full | Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis |
title_fullStr | Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis |
title_full_unstemmed | Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis |
title_short | Right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis |
title_sort | right ventricular–pulmonary artery coupling in cardiac resynchronization therapy: evolution and prognosis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065855/ https://www.ncbi.nlm.nih.gov/pubmed/35266319 http://dx.doi.org/10.1002/ehf2.13857 |
work_keys_str_mv | AT stassenjan rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis AT gallooxavier rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis AT hirasawakensuke rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis AT chimedsurenjav rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis AT marsanninaajmone rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis AT delgadovictoria rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis AT vanderbijlpieter rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis AT baxjeroenj rightventricularpulmonaryarterycouplingincardiacresynchronizationtherapyevolutionandprognosis |